Data on ARBs continue to impress. Stay informed on the implications of late-breaking trial data from the 2008 ESC meeting with interviews conducted by Dr Weber with Drs Pfeffer, McMurray, Swedberg, and Agabati-Rosei.
Hypertension, hypercholesterolemia, insulin resistance, atherosclerosis, coronary heart disease, heart failure: are they all at the mercy of nitric oxide? Join Drs Weber, Cohn, Mason and Cockcroft in a discussion on the role nitric oxide plays in vascular health.
The assessment of microalbuminuria (MAU) is an important prognostic indicator for CVD and renal damage and should be an element in an overall cardiometabolic fitness approach.
Angiotensin receptor blockers, primarily known as safe and effective antihypertensive agents, are not generally recognized as having a dramatic dose response effect on blood pressure, that is. But these agents do more than lower BP. New data from SMART (SupraMaximal Doses of Atacand and Renal Therapy) show surprising effects on proteinuria.
Data on ARBs continue to impress. Stay informed on the implications of late-breaking trial data from the 2008 ESC meeting with interviews conducted by Dr Weber with Drs Pfeffer, McMurray, Swedberg, and Agabati-Rosei.
Hypertension, hypercholesterolemia, insulin resistance, atherosclerosis, coronary heart disease, heart failure: are they all at the mercy of nitric oxide? Join Drs Weber, Cohn, Mason and Cockcroft in a discussion on the role nitric oxide plays in vascular health.
The assessment of microalbuminuria (MAU) is an important prognostic indicator for CVD and renal damage and should be an element in an overall cardiometabolic fitness approach.